| |
Notice of the making of this Statutory Instrument was published in
|
| |
“Iris Oifigiúil” of 1st March, 2022.
|
| |
I, STEPHEN DONNELLY, in exercise of the powers conferred on me by
section 32
(as amended by
section 16
of the
Irish Medicines Board (Miscellaneous Provisions) Act 2006
(No. 3 of 2006)) of the
Irish Medicines Board Act 1995
(No. 29 of 1995), hereby make the following regulations:
|
| |
1. (1) These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2022.
|
| |
(2) The collective citation “the Medicinal Products (Prescription and Control of Supply) Regulations 2003 to 2022” includes these Regulations.
|
| |
2. In these Regulations—
|
| |
“Principal Regulations” means the Medicinal Products (Prescription and Control of Supply) Regulations 2003 (
S.I. No. 540 of 2003
);
|
| |
“Regulations of 2022” means the Medicinal Products (Prescription and Control of Supply (Amendment) (No. 2) Regulations 2022 (
S.I. No. 57 of 2022
).
|
| |
3. The Eighth Schedule (as amended by Regulation 3 of the Regulations of 2022) to the Principal Regulations is amended, in column 5 of the entry for “Comirnaty concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified)”, by substituting “12 years of age” for “16 years of age”.
|
| |
4. The Twelfth Schedule (as amended by Regulation 4 of the Regulations of 2022) to the Principal Regulations is amended, in column 5 of the entry for “Comirnaty concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified)”, by substituting “12 years of age” for “16 years of age”.
|
| |
![http://www.irishstatutebook.ie/images/ls](http://www.irishstatutebook.ie/images/ls)
|
| |
GIVEN under my Official Seal,
|
| |
24 February, 2022.
|
| |
STEPHEN DONNELLY,
|
| |
Minister for Health.
|
| |
EXPLANATORY NOTE
|
| |
(This note is not part of the Instrument and does not purport to be a legal interpretation.)
|
| |
These Regulations amend the Medicinal Products (Prescription and Control of Supply) Regulations 2003.
|
| |
The purpose of these Regulations is to allow for booster doses of the Comirnaty Covid-19 vaccine to be administered to persons between 12 and 15 years of age.
|
| |
These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2022.
|